These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16949305)

  • 1. Assessing nigrostriatal dysfunctions by pharmacological MRI in parkinsonian rhesus macaques.
    Zhang Z; Andersen AH; Ai Y; Loveland A; Hardy PA; Gerhardt GA; Gash DM
    Neuroimage; 2006 Nov; 33(2):636-43. PubMed ID: 16949305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validations of apomorphine-induced BOLD activation correlations in hemiparkinsonian rhesus macaques.
    Quintero JE; Ai Y; Andersen AH; Hardy P; Grondin R; Guduru Z; Gash DM; Gerhardt GA; Zhang Z
    Neuroimage Clin; 2019; 22():101724. PubMed ID: 30822717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway.
    Riverol M; Ordóñez C; Collantes M; DiCaudo C; Peñuelas I; Arbizu J; Marcilla I; Luquin MR
    Neurobiol Dis; 2014 Feb; 62():250-9. PubMed ID: 24076099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI detects acute degeneration of the nigrostriatal dopamine system after MPTP exposure in hemiparkinsonian monkeys.
    Miletich RS; Bankiewicz KS; Quarantelli M; Plunkett RJ; Frank J; Kopin IJ; Di Chiro G
    Ann Neurol; 1994 Jun; 35(6):689-97. PubMed ID: 8210225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
    Antonini A; Schwarz J; Oertel WH; Pogarell O; Leenders KL
    Mov Disord; 1997 Jan; 12(1):33-8. PubMed ID: 8990051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
    Rioux L; Frohna PA; Joyce JN; Schneider JS
    Mov Disord; 1997 Mar; 12(2):148-58. PubMed ID: 9087972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric dopaminergic degeneration and levodopa alter functional corticostriatal connectivity bilaterally in experimental parkinsonism.
    Monnot C; Zhang X; Nikkhou-Aski S; Damberg P; Svenningsson P
    Exp Neurol; 2017 Jun; 292():11-20. PubMed ID: 28223037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Objectively measuring effects of electro-acupuncture in parkinsonian rhesus monkeys.
    Zhang R; Andersen AH; Hardy PA; Forman E; Evans A; Ai Y; Yue J; Yue G; Gash DM; Grondin R; Zhang Z
    Brain Res; 2018 Jan; 1678():12-19. PubMed ID: 29017909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model.
    Di Monte DA; McCormack A; Petzinger G; Janson AM; Quik M; Langston WJ
    Mov Disord; 2000 May; 15(3):459-66. PubMed ID: 10830409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intermittent washout periods on progressive lesioning of the nigrostriatal pathway with 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Goldberg NR; Meshul CK
    Neuroscience; 2011 May; 182():203-7. PubMed ID: 21402128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic MRI (phMRI) as a tool to differentiate Parkinson's disease-related from age-related changes in basal ganglia function.
    Andersen AH; Hardy PA; Forman E; Gerhardt GA; Gash DM; Grondin RC; Zhang Z
    Neurobiol Aging; 2015 Feb; 36(2):1174-82. PubMed ID: 25443764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological MRI mapping of age-associated changes in basal ganglia circuitry of awake rhesus monkeys.
    Zhang Z; Andersen A; Grondin R; Barber T; Avison R; Gerhardt G; Gash D
    Neuroimage; 2001 Nov; 14(5):1159-67. PubMed ID: 11697947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 2. Intracerebral microinjection of dopamine agonists and antagonists.
    Okamura H; Murakami T; Yokoyama C; Nakamura T; Ibata Y
    J Pharmacol Exp Ther; 1997 Feb; 280(2):1031-7. PubMed ID: 9023320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion.
    Sindhu KM; Saravanan KS; Mohanakumar KP
    Brain Res; 2005 Jul; 1051(1-2):25-34. PubMed ID: 15992782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional MRI of apomorphine activation of the basal ganglia in awake rhesus monkeys.
    Zhang Z; Andersen AH; Avison MJ; Gerhardt GA; Gash DM
    Brain Res; 2000 Jan; 852(2):290-6. PubMed ID: 10678755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling changes in gait dynamics resulting from progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigrostriatal lesioning.
    Goldberg NR; Hampton T; McCue S; Kale A; Meshul CK
    J Neurosci Res; 2011 Oct; 89(10):1698-706. PubMed ID: 21748776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine turnover is upregulated in the caudate/putamen of asymptomatic MPTP-treated rhesus monkeys.
    Pifl C; Hornykiewicz O
    Neurochem Int; 2006 Oct; 49(5):519-24. PubMed ID: 16698121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-Dopa treatment abolishes the numerical increase in striatal dopaminergic neurons in parkinsonian monkeys.
    Huot P; Lévesque M; Morissette M; Calon F; Dridi M; Di Paolo T; Parent A
    J Chem Neuroanat; 2008 Jan; 35(1):77-84. PubMed ID: 17706922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping dopamine function in primates using pharmacologic magnetic resonance imaging.
    Jenkins BG; Sanchez-Pernaute R; Brownell AL; Chen YC; Isacson O
    J Neurosci; 2004 Oct; 24(43):9553-60. PubMed ID: 15509742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative diffusion tensor imaging detects dopaminergic neuronal degeneration in a murine model of Parkinson's disease.
    Boska MD; Hasan KM; Kibuule D; Banerjee R; McIntyre E; Nelson JA; Hahn T; Gendelman HE; Mosley RL
    Neurobiol Dis; 2007 Jun; 26(3):590-6. PubMed ID: 17428671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.